The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27876250 |
60 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH |
Jagiellonian University Medical College |
26988801 |
55 |
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents. |
Jagiellonian University Medical College |
26390077 |
42 |
Tactical Approaches to Interconverting GPCR Agonists and Antagonists. |
University of Minnesota |
26810314 |
12 |
Structural determinants of subtype selectivity and functional activity of angiotensin II receptors. |
Uppsala University |
25699147 |
6 |
Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands. |
Uppsala University |
25313325 |
8 |
Saralasin and Sarile Are AT2 Receptor Agonists. |
Universit£ |
21413808 |
170 |
Synopsis of some recent tactical application of bioisosteres in drug design. |
Bristol-Myers Squibb Pharmaceutical Research and Development |
20875743 |
90 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity rela |
Pfizer |
20493713 |
30 |
Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition. |
Uppsala University |
17358051 |
13 |
Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor. |
Uppsala University |
17004728 |
4 |
Design, synthesis, and incorporation of a beta-turn mimetic in angiotensin II forming novel pseudopeptides with affinity for AT1 and AT2 receptors. |
Uppsala University |
16220978 |
14 |
Angiotensin II pseudopeptides containing 1,3,5-trisubstituted benzene scaffolds with high AT2 receptor affinity. |
Uppsala University |
16220969 |
219 |
Designed multiple ligands. An emerging drug discovery paradigm. |
Organon Laboratories |
15943474 |
10 |
New selective AT2 receptor ligands encompassing a gamma-turn mimetic replacing the amino acid residues 4-5 of angiotensin II act as agonists. |
Uppsala University |
15537355 |
4 |
AT2-selective angiotensin II analogues containing tyrosine-functionalized 5,5-bicyclic thiazabicycloalkane dipeptide mimetics. |
Uppsala University |
15537354 |
14 |
Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. |
Uppsala University |
7241506 |
40 |
New analgesic drugs derived from phencyclidine. |
TBA |
14761188 |
8 |
A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II. |
Uppsala University |
8576904 |
78 |
Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy. |
Dupont Pharmaceuticals |
| 32 |
L-161,638: A potent AT2selective quinazolinone angiotensin II binding inhibitor |
TBA |
| 4 |
The syntheses and binding affinities of tools for the study of angiotensin AT2 receptors |
TBA |
22309912 |
28 |
Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists. |
Beijing Institute of Technology |
21557540 |
39 |
Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-¿. |
Pfizer |
21071232 |
78 |
Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective. |
The M. S. University of Baroda |
| 42 |
Balanced AT1 and AT2 angiotensin II antagonists. II. Potent 5 α-hydroxyacid imidazolyl biphenyl sulfonylureas |
TBA |
| 17 |
AT1 selective angiotensin II antagonists with phenoxyphenylacetic acid as a biphenyl replacement part I |
TBA |
| 56 |
Potent triazolinone-based angiotensin II receptor antagonists with equivalent affinity for both the AT1 and AT2 subtypes |
TBA |
| 134 |
Development of angiotensin II antagonists with equipotent affinity for human AT1 and AT2 receptor subtypes. |
TBA |
| 122 |
Balanced angiotensin II receptor antagonists. III. The effects of substitution at the imidazole 5-position. |
TBA |
| 68 |
Balanced angiotensin II receptor antagonists. II.1,2 4-aminomethyl- and acylaminomethylimidazoles |
TBA |
| 19 |
Imidazolinones as nonpeptide angiotensin II receptor antagonists |
TBA |
| 21 |
Tetrahydroisoquinoline derivatives with AT2-specific angiotensin II reception binding inhibitory activity |
TBA |
| 1 |
4,5,6,7-Tetrahdryo-8-oxo-cycloheptimidazoles: a new class of potent non-peptide angiiotensin II receptor antagonists |
TBA |
19447613 |
9 |
Nocathiacin analogs: Synthesis and antibacterial activity of novel water-soluble amides. |
Merck Research Laboratories |
17125268 |
44 |
Selective angiotensin II AT2 receptor agonists: arylbenzylimidazole structure-activity relationships. |
Uppsala University |
14998339 |
22 |
First reported nonpeptide AT1 receptor agonist (L-162,313) acts as an AT2 receptor agonist in vivo. |
Uppsala University |
32030982 |
14 |
The Other Angiotensin II Receptor: AT |
Centre Hospitalier Universitaire Vaudois (Chuv) and University of Lausanne (Unil |
30655952 |
89 |
Discovery of TD-0212, an Orally Active Dual Pharmacology AT |
Theravance Biopharma Us |
8515427 |
43 |
Multiple binding modes for the receptor-bound conformations of cyclic AII agonists. |
Washington University |
8201597 |
10 |
Non-peptide angiotensin II receptor antagonists: synthesis and biological activity of a series of novel 4,5-dihydro-4-oxo-3H-imidazo[4,5-c]pyridine derivatives. |
E. Merck |
24200932 |
2 |
Design, synthesis, and biological evaluation of 1,2,4-triazole bearing 5-substituted biphenyl-2-sulfonamide derivatives as potential antihypertensive candidates. |
China Pharmaceutical University |
24007859 |
33 |
Nonpeptidic angiotensin II AT? receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles. |
Beijing Institute of Technology |
7562906 |
3 |
Derivatives of 5-[[1-(4'-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonists. |
Warner-Lambert |
7562905 |
258 |
Potent and orally active angiotensin II receptor antagonists with equal affinity for human AT1 and AT2 subtypes. |
Merck Research Laboratories |
29969256 |
21 |
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction. |
Universitaire Vaudois |
9225286 |
13 |
SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. |
Smithkline Beecham Pharmaceuticals |
18579376 |
23 |
Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. |
Kudos Pharmaceuticals |
19138518 |
51 |
Investigation on the role of the tetrazole in the binding of thiotetrazolylacetanilides with HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases. |
Boehringer Ingelheim (Canada) |
14695825 |
67 |
Potent inhibitors of the Plasmodium falciparum enzymes plasmepsin I and II devoid of cathepsin D inhibitory activity. |
Uppsala University |
12139449 |
114 |
Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives. |
University of Newcastle |